Physiological pharmacokinetics and cancer risk assessment.
about
Current trends in toxicological risk assessment: perspectives from the committee on toxicology.Expression of exposure in negative carcinogenicity studies: dose/body weight, dose/body surface area, or plasma concentrations?Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.Biokinetics and biokinetic models in risk assessment.Population toxicokinetics of benzeneRoute-of-entry and brain tissue partition coefficients for common superfund contaminants.Uncertainty, Variability, and Sensitivity Analysis in Physiological Pharmacokinetic Models
P2860
Q34154133-33FAB668-79A1-4616-8CDE-514C4EED78EFQ40418745-4F9D09C5-E1E0-4CD9-B898-4659181EC181Q41041971-F166F8ED-3D99-40ED-A607-B3D667E014FCQ41200971-3B8F6991-3E80-43DA-B889-464DBB09B8F5Q42008033-CA4BD260-EA64-47C7-85C9-ADA2C155B802Q44270950-3CE6EE96-A296-4943-AA7E-821C16577D98Q57491919-DCFF5581-A5EF-413B-81DD-C56501482F8F
P2860
Physiological pharmacokinetics and cancer risk assessment.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Physiological pharmacokinetics and cancer risk assessment.
@en
type
label
Physiological pharmacokinetics and cancer risk assessment.
@en
prefLabel
Physiological pharmacokinetics and cancer risk assessment.
@en
P1433
P1476
Physiological pharmacokinetics and cancer risk assessment
@en
P2093
J R Withey
P356
10.1016/0304-3835(93)90025-5
P407
P577
1993-04-01T00:00:00Z